{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:48:51Z","timestamp":1791748131041,"version":"4.3.4"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020206","name":"Shandong Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006579","name":"Ministry of Industry and Information Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108866","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:08:02Z","timestamp":1791389282000},"page":"108866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Respiratory viruses and pulmonary diseases: Mechanisms, therapies, and metabolic reprogramming"],"prefix":"10.1016","volume":"221","author":[{"given":"Mengwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108866_bib1","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S1473-3099(17)30238-4","article-title":"Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance","volume":"17","author":"Tang","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108866_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1378\/chest.130.4.1203","article-title":"How viral infections cause exacerbation of airway diseases","volume":"130","author":"Mallia","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2026.108866_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2026.108866_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccm.2016.11.014","article-title":"Respiratory viral infections in chronic lung diseases","volume":"38","author":"Britto","year":"2017","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.micpath.2026.108866_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/aac2.12044","article-title":"The critical function of metabolic reprogramming in cancer metastasis","volume":"3","author":"Xie","year":"2022","journal-title":"Aging and Cancer"},{"key":"10.1016\/j.micpath.2026.108866_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.micpath.2026.108866_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2026.04.003","article-title":"Epigenetic remodeling after viral pneumonia accelerates lung tumorigenesis","volume":"32","author":"Liu","year":"2026","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2026.02.013","article-title":"Respiratory viral infections prime accelerated lung cancer growth","volume":"189","author":"Qian","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00407-2019","article-title":"Time-course of upper respiratory tract viral infection and COPD exacerbation","volume":"54","author":"Stolz","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2026.108866_bib10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid2308.170059","article-title":"Influenza D virus in animal species in Guangdong province, Southern China","volume":"23","author":"Zhai","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108866_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038778","article-title":"Influenza hemagglutinin structures and antibody recognition","volume":"10","author":"Wu","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3390\/v14102141","article-title":"Influence of host sialic acid receptors structure on the host specificity of influenza viruses","volume":"14","author":"Zhao","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib13","first-page":"1","article-title":"Exploration of the sialic acid world","volume":"75","author":"Schauer","year":"2018","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.micpath.2026.108866_bib14","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3390\/v15112141","article-title":"ZBP1 drives IAV-induced NLRP3 inflammasome activation and lytic cell death, PANoptosis, independent of the necroptosis executioner MLKL","volume":"15","author":"Malireddi","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.celrep.2017.04.039","article-title":"Targeting metabolic reprogramming by influenza infection for therapeutic intervention","volume":"19","author":"Smallwood","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2026.108866_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus--a comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib17","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib18","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1097\/CM9.0000000000003354","article-title":"Landscape of respiratory syncytial virus","volume":"137","author":"Duan","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.micpath.2026.108866_bib19","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.7150\/ijbs.64762","article-title":"Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies","volume":"17","author":"Shang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micpath.2026.108866_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00010-21","article-title":"CX3CR1 is a receptor for human respiratory syncytial virus in cotton rats","volume":"95","author":"Green","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib21","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/v13102055","article-title":"Metabolic reprogramming of Nasal airway epithelial cells following infant respiratory syncytial virus infection","volume":"13","author":"Connelly","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ympev.2023.107704","article-title":"Bioinformatic analysis of the S protein of human respiratory coronavirus","volume":"181","author":"Niu","year":"2023","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.micpath.2026.108866_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105246","article-title":"Human coronaviruses: origin, host and receptor","volume":"155","author":"Tang","year":"2022","journal-title":"J. Clin. Virol. : the off. Publi. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaa057","article-title":"Molecular diversity of coronavirus host cell entry receptors","volume":"45","author":"Millet","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108866_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108866_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib27","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108866_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0092-8674(89)90688-0","article-title":"The major human rhinovirus receptor is ICAM-1","volume":"56","author":"Greve","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib30","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.1421178112","article-title":"Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication","volume":"112","author":"Bochkov","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108866_bib31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.chest.2018.12.012","article-title":"Rhinoviruses and their receptors","volume":"155","author":"Basnet","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2026.108866_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12931-025-03178-w","article-title":"Hidden in plain sight: the impact of human rhinovirus infection in adults","volume":"26","author":"Morelli","year":"2025","journal-title":"Respir. Res."},{"key":"10.1016\/j.micpath.2026.108866_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/v14010141","article-title":"Understanding Rhinovirus circulation and impact on illness","volume":"14","author":"Esneau","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1800525115","article-title":"Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication","volume":"115","author":"Gualdoni","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108866_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/pathogens11020150","article-title":"Immune responses to IAV infection and the roles of L-Selectin and ADAM17 in lymphocyte homing","volume":"11","author":"Reed","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108866_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s11658-020-00211-2","article-title":"Metabolic host response and therapeutic approaches to influenza infection","volume":"25","author":"Keshavarz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.micpath.2026.108866_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/00325481.1964.11695112","article-title":"Clinical significance of respiratory syncytial virus","volume":"35","author":"Coates","year":"1964","journal-title":"PGM (Postgrad. Med.)"},{"key":"10.1016\/j.micpath.2026.108866_bib39","first-page":"39","article-title":"Clinical and epidemiologic features of respiratory syncytial virus","volume":"372","author":"Hall","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2514357","article-title":"Respiratory syncytial virus (RSV) infections in adults: current trends and recommendations for prevention - a global challenge from a local perspective","volume":"21","author":"Tanriover","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2026.108866_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176271","article-title":"Luteolin-7-O-glucoside promotes macrophage release of IFN-\u03b2 by maintaining mitochondrial function and corrects the disorder of glucose metabolism during RSV infection","volume":"963","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108866_bib42","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/biom15071027","article-title":"Metabolic reprogramming in respiratory viral infections: a focus on SARS-CoV-2, influenza, and respiratory syncytial virus","volume":"15","author":"Camps","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2026.108866_bib43","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/v13102068","article-title":"Metabolic modifications by common respiratory viruses and their potential as new antiviral targets","volume":"13","author":"Kleinehr","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib44","article-title":"Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2","volume":"8","author":"Wali","year":"2022","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.micpath.2026.108866_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","article-title":"Respiratory viral infections awaken metastatic breast cancer cells in lungs","volume":"645","author":"Chia","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108866_bib46","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00300.2023","article-title":"Early-life pulmonary viral infection leads to long-term functional and lower airway structural changes in the lungs","volume":"326","author":"Malinczak","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.micpath.2026.108866_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abk1741","article-title":"Immune signatures underlying post-acute COVID-19 lung sequelae","volume":"6","author":"Cheon","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib48","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201205-0806OC","article-title":"Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease","volume":"186","author":"Mallia","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2026.108866_bib49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1517\/14728222.2011.599801","article-title":"The role of inflammation in the pathogenesis of lung cancer","volume":"15","author":"Cho","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.micpath.2026.108866_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0063-2018","article-title":"Respiratory viral infection: a potential \"missing link\" in the pathogenesis of COPD","volume":"28","author":"Linden","year":"2019","journal-title":"Eur. Respir. Rev. : an offi. J. Eur. Res. Soc."},{"key":"10.1016\/j.micpath.2026.108866_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40121-024-01081-3","article-title":"A narrative review of key risk factors for severe illness following SARS-CoV-2, influenza virus, and respiratory syncytial virus infection","volume":"14","author":"Branche","year":"2025","journal-title":"Infectious diseases and therapy"},{"key":"10.1016\/j.micpath.2026.108866_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/v8050124","article-title":"Respiratory syncytial virus and cellular stress responses: impact on replication and physiopathology","volume":"8","author":"Cervantes-Ortiz","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1744666X.2025.2494658","article-title":"Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review","volume":"21","author":"Chaumont","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib54","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/irv.13004","article-title":"Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2","volume":"16","author":"Hamilton","year":"2022","journal-title":"Influenza and other Respiratory Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-026-03526-4","article-title":"Respiratory syncytial virus is associated with a higher disease burden than influenza and SARS-CoV-2 in adults with chronic lung disease: a multi-center cohort study","volume":"27","author":"Sun","year":"2026","journal-title":"Respir. Res."},{"key":"10.1016\/j.micpath.2026.108866_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0248-2025","article-title":"Immunosenescence and susceptibility to respiratory viruses: a state-of-the-art review","volume":"35","author":"Fragkou","year":"2026","journal-title":"Eur. Respir. Rev. : an offi. J. Eur. Res. Soc."},{"key":"10.1016\/j.micpath.2026.108866_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cells14151177","article-title":"Oxidative and glycolytic metabolism: their reciprocal regulation and dysregulation in cancer","volume":"14","author":"Cordani","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108866_bib58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.csbj.2023.01.044","article-title":"Hybrid computational models of multicellular tumour growth considering glucose metabolism","volume":"21","author":"Gon\u00e7alves","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2026.108866_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02110-23","article-title":"Respiratory syncytial virus co-opts hypoxia-inducible factor-1\u03b1-mediated glycolysis to favor the production of infectious virus","volume":"14","author":"Chen","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108866_bib60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.micpath.2026.108866_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00074-25","article-title":"CypA inhibits respiratory syncytial virus (RSV) replication by suppressing glycolysis through the downregulation of PKM2 expression","volume":"99","author":"Zhang","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11306-023-01991-2","article-title":"Analysis of temporal metabolic rewiring for human respiratory syncytial virus infection by integrating metabolomics and proteomics","volume":"19","author":"Lu","year":"2023","journal-title":"Metabolomics : Off. J. Metabo. Soc."},{"key":"10.1016\/j.micpath.2026.108866_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/v17050703","article-title":"Respiratory syncytial virus elicits glycolytic metabolism in pediatric upper and lower airways","volume":"17","author":"Flores-Torres","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib64","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/v16060910","article-title":"Respiratory virus-induced PARP1 alters DC metabolism and antiviral immunity inducing pulmonary immunopathology","volume":"16","author":"Mire","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2020.07.019","article-title":"Experimental validation of influenza A virus matrix protein (M1) interaction with host cellular alpha enolase and pyruvate kinase","volume":"549","author":"Mishra","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2026.108866_bib66","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/metabo11100699","article-title":"Targeting the pentose phosphate pathway for SARS-CoV-2 therapy","volume":"11","author":"Bojkova","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.micpath.2026.108866_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110068","article-title":"Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication","volume":"595","author":"Ueno","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2026.108866_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molmed.2023.06.001","article-title":"SARS-CoV-2 targets the liver and manipulates glucose metabolism","volume":"29","author":"Pirola","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib69","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/ijms24010558","article-title":"HIF-1\u03b1-Dependent metabolic reprogramming, oxidative stress, and bioenergetic dysfunction in SARS-CoV-2-Infected hamsters","volume":"24","author":"Jana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108866_bib70","article-title":"Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational","volume":"131","author":"Mansouri","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.micpath.2026.108866_bib71","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12964-024-01983-2","article-title":"STING exerts antiviral innate immune response by activating pentose phosphate pathway","volume":"22","author":"Wu","year":"2024","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.micpath.2026.108866_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.725043","article-title":"The role of tricarboxylic acid cycle metabolites in viral infections","volume":"11","author":"S\u00e1nchez-Garc\u00eda","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/dmpt-2022-0148","article-title":"A metabolic blueprint of COVID-19 and long-term vaccine efficacy","volume":"38","author":"Berber","year":"2023","journal-title":"Drug Metabolism And Personalized Therapy"},{"key":"10.1016\/j.micpath.2026.108866_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67879-6","article-title":"Influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice","volume":"10","author":"Ohno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108866_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107170","article-title":"SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19","volume":"204","author":"Guarnieri","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.micpath.2026.108866_bib77","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells10051118","article-title":"Multifaceted role of AMPK in viral infections","volume":"10","author":"Bhutta","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108866_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008319","article-title":"Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells","volume":"16","author":"Elesela","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108866_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42448","article-title":"Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production","volume":"8","author":"Hu","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.micpath.2026.108866_bib80","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/v15122380","article-title":"Mitochondrial oxidative phosphorylation in viral infections","volume":"15","author":"Purandare","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.631274","article-title":"Membrane rafts: portals for viral entry","volume":"12","author":"Ripa","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib82","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.1701325","article-title":"TGF-\u03b21 suppresses the type I IFN response and induces mitochondrial dysfunction in alveolar macrophages","volume":"200","author":"Grunwell","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib83","article-title":"KSHV reprogramming of host energy metabolism for pathogenesis","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.685196","article-title":"Changes in glycolytic pathway in SARS-COV 2 infection and their importance in understanding the severity of COVID-19","volume":"9","author":"Santos","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.micpath.2026.108866_bib85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/bs.apcsb.2023.12.003","article-title":"Decoding macrophage immunometabolism in human viral infection","volume":"140","author":"Malemnganba","year":"2024","journal-title":"Advances In Protein Chem. Struct. Bio."},{"key":"10.1016\/j.micpath.2026.108866_bib86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s44298-025-00090-4","article-title":"Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis","volume":"3","author":"Kleinehr","year":"2025","journal-title":"Npj viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011371","article-title":"Senecavirus A-induced glycolysis facilitates virus replication by promoting lactate production that attenuates the interaction between MAVS and RIG-I","volume":"19","author":"Li","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108866_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: failure of resolution of inflammation?","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib89","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-021-00532-4","article-title":"Targeting glucose metabolism for treatment of COVID-19","volume":"6","author":"Ardestani","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29807","article-title":"Immunometabolites in viral infections: action mechanism and function","volume":"96","author":"Bouzari","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2026.108866_bib91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10517-017-3678-1","article-title":"Study of SMAD-dependent signal pathway in the development of early pulmonary fibrosis in mice infected with influenza A\/H1N1 virus","volume":"162","author":"Shatskaya","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/infdis\/jis340","article-title":"Critical role of natural killer cells in lung immunopathology during influenza infection in mice","volume":"206","author":"Abdul-Careem","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108866_bib93","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.semcancer.2021.01.003","article-title":"Epigenetic underpinnings of inflammation: connecting the dots between pulmonary diseases, lung cancer and COVID-19","volume":"83","author":"Ahmad","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.micpath.2026.108866_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44880-3","article-title":"Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes","volume":"13","author":"Hochmann","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108866_bib95","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","article-title":"Oxidative stress and its role in cancer","volume":"17","author":"Jelic","year":"2021","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.micpath.2026.108866_bib96","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/antiox14060735","article-title":"Oxidative stress and inflammation: drivers of tumorigenesis and therapeutic opportunities","volume":"14","author":"Wang","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.micpath.2026.108866_bib97","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/jcm9030867","article-title":"Evaluation of proinflammatory, NF-kappaB dependent cytokines: Il-1\u03b1, IL-6, IL-8, and TNF-\u03b1 in tissue specimens and saliva of patients with oral squamous cell carcinoma and oral potentially malignant disorders","volume":"9","author":"Babiuch","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.688625","article-title":"The role of tumor inflammatory microenvironment in lung cancer","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108866_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101413","article-title":"The double-edged sword: how SARS-CoV-2 might fuel lung cancer: investigating the potential oncogenic mechanisms of the novel coronavirus in lung carcinogenesis","volume":"106","author":"Shen","year":"2025","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110074","article-title":"Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?","volume":"143","author":"Tao","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.micpath.2026.108866_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(92)90047-4","article-title":"Carcinogen-mediated oxidant formation and oxidative DNA damage","volume":"53","author":"Frenkel","year":"1992","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib102","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.it.2025.03.007","article-title":"Epstein-Barr virus-mediated immune evasion in tumor promotion","volume":"46","author":"Yuan","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib103","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41556-023-01096-x","article-title":"SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence","volume":"25","author":"Gioia","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.micpath.2026.108866_bib104","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.3390\/ijms22158346","article-title":"Role of virus-induced host cell epigenetic changes in cancer","volume":"22","author":"Pietropaolo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108866_bib105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-020-00295-7","article-title":"Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers","volume":"15","author":"Tavakolian","year":"2020","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.micpath.2026.108866_bib106","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/cancers13020241","article-title":"Tampering of viruses and bacteria with host DNA repair: implications for cellular transformation","volume":"13","author":"Benedetti","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.micpath.2026.108866_bib107","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/cells13181519","article-title":"YAP\/TAZ signaling in the pathobiology of pulmonary fibrosis","volume":"13","author":"Papavassiliou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108866_bib108","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0126-2020","article-title":"The ageing lung under stress","volume":"29","author":"Korfei","year":"2020","journal-title":"Eur. Respir. Rev. : an offi. J. Eur. Res. Soc."},{"key":"10.1016\/j.micpath.2026.108866_bib109","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"PTTG1 Reprograms Asparagine metabolism to promote hepatocellular carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2026.108866_bib110","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.3390\/ijms26209853","article-title":"Human small airway epithelia reveal dichloroacetate as a broad-spectrum antiviral against respiratory viruses","volume":"26","author":"Mart\u00ednez de Iturrate","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108866_bib111","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0042-6822(75)90431-6","article-title":"Effect of 2-deoxy-D-glucose and glucosamine on the growth and functions of respiratory syncytial and parainfluenza 3 viruses","volume":"67","author":"Schnitzer","year":"1975","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2026.108866_bib112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14050-y","article-title":"Small-molecule metabolome identifies potential therapeutic targets against COVID-19","volume":"12","author":"Bennet","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108866_bib114","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1515\/cclm-2023-1017","article-title":"Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD(+) pathway and SIRT1 activation","volume":"62","author":"Lonati","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-018-0224-x","article-title":"Mechanism of parkin activation by PINK1","volume":"559","author":"Gladkova","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108866_bib116","article-title":"SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment","volume":"12","author":"Shang","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib117","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1080\/15548627.2020.1812218","article-title":"Autophagic protein ATG5 controls antiviral immunity via glycolytic reprogramming of dendritic cells against respiratory syncytial virus infection","volume":"17","author":"Oh","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.micpath.2026.108866_bib118","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/15548627.2020.1761653","article-title":"Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression","volume":"17","author":"Wu","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.micpath.2026.108866_bib119","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/2326-6066.CIR-24-0469","article-title":"Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment","volume":"12","author":"Rahal","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.micpath.2026.108866_bib120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10565-016-9322-4","article-title":"Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia","volume":"32","author":"Chen","year":"2016","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.micpath.2026.108866_bib121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s42255-021-00507-3","article-title":"Viral infection as an NAD(+) battlefield","volume":"4","author":"Brenner","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.micpath.2026.108866_bib122","article-title":"Fc-fused IL-7 provides broad antiviral effects against respiratory virus infections through IL-17A-producing pulmonary innate-like T cells","volume":"5","author":"Kwon","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01972-25","article-title":"Anti-RSV drug screening and inhibition of RSV infection by lapatinib through the IL-17 pathway","volume":"70","author":"Sun","year":"2026","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108866_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106211","article-title":"Efficacy and safety of respiratory syncytial virus prefusion F protein vaccines in adults","volume":"89","author":"Du","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2026.108866_bib125","doi-asserted-by":"crossref","first-page":"Jc63","DOI":"10.7326\/J23-0039","article-title":"In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease","volume":"176","author":"Awar","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib126","article-title":"Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: a systematic review and meta-analysis","volume":"146","author":"Zeng","year":"2024","journal-title":"Int. J. Infect. Dis. : IJID : official publication of the International Society for Infectious Diseases"},{"key":"10.1016\/j.micpath.2026.108866_bib127","article-title":"Influenza vaccines in immunosuppressed adults with cancer","volume":"2","author":"Bitterman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.micpath.2026.108866_bib128","doi-asserted-by":"crossref","first-page":"e4269","DOI":"10.1093\/cid\/ciaa1711","article-title":"A randomized trial of two 2-Dose influenza vaccination strategies for patients following autologous hematopoietic stem cell transplantation","volume":"73","author":"Teh","year":"2021","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2026.108866_bib129","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001022","article-title":"Effect of 23-Valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study","volume":"94","author":"Chiou","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.micpath.2026.108866_bib130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018035","article-title":"Effect of annual influenza vaccination on reducing lung cancer in patients with chronic obstructive pulmonary disease from a population-based cohort study","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.micpath.2026.108866_bib131","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.3390\/cancers14122926","article-title":"Influenza vaccination and risk of lung cancer in patients with chronic kidney disease: a nationwide, population-based cohort study","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.micpath.2026.108866_bib132","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/1055-9965.EPI-25-0617","article-title":"Antiviral treatment reduces risk of development of lung cancer and non-hodgkin lymphoma in patients with chronic hepatitis C","volume":"34","author":"Tao","year":"2025","journal-title":"Cancer Epidemiol. Biomarkers Prev. : a publi. Am. Assoc. Cancer Res. cosponsored by the Am. Soc. Prevent. Oncol."},{"key":"10.1016\/j.micpath.2026.108866_bib133","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer","volume":"117","author":"Newman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108866_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.10.006","article-title":"Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment","volume":"185","author":"Baharom","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib135","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib136","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2020.01906","article-title":"Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib137","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1038\/s41467-024-49059-6","article-title":"Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108866_bib138","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","article-title":"Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization","volume":"14","author":"Cassidy-Stone","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.micpath.2026.108866_bib139","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66401-8","article-title":"\u03b2(2)-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection","volume":"16","author":"Adhikari","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108866_bib140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.03947-14","article-title":"Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro","volume":"59","author":"Belardo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108866_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010481","article-title":"Preclinical and clinical developments for combination treatment of influenza","volume":"18","author":"Koszalka","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108866_bib142","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ajpath.2020.12.013","article-title":"Administration of a CXC chemokine receptor 2 (CXCR2) antagonist, SCH527123, together with Oseltamivir suppresses NETosis and protects mice from Lethal Influenza and piglets from Swine-Influenza infection","volume":"191","author":"Ashar","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.micpath.2026.108866_bib143","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14787210.3.6.945","article-title":"Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection","volume":"3","author":"Blanco","year":"2005","journal-title":"Expert Rev. Anti-infective Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib144","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3851\/IMP2080","article-title":"Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis","volume":"22","author":"Murray","year":"2012","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.micpath.2026.108866_bib145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2026.108866_bib146","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/irv.12725","article-title":"A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA\/I38X amino acid substitutions","volume":"14","author":"Koszalka","year":"2020","journal-title":"Influenza and other Respiratory Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70269","article-title":"Antiviral resistance in influenza: clinical and public health implications","volume":"20","author":"Ngiam","year":"2026","journal-title":"Influenza and other Respiratory Viruses"},{"key":"10.1016\/j.micpath.2026.108866_bib148","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid3105.241123","article-title":"Influenza A(H1N1)pdm09 virus with reduced susceptibility to Baloxavir, Japan, 2024","volume":"31","author":"Takashita","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108866_bib149","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(24)00570-X","article-title":"Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study","volume":"25","author":"Fourati","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108866_bib150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166032","article-title":"Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments","volume":"133","author":"Gupta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108866_bib151","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciad494","article-title":"Nirmatrelvir Resistance-de Novo E166V\/L50V mutations in an immunocompromised patient treated with prolonged Nirmatrelvir\/Ritonavir monotherapy leading to clinical and virological treatment Failure-a case report","volume":"78","author":"Zuckerman","year":"2024","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.micpath.2026.108866_bib152","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168603","article-title":"SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern","volume":"133","author":"Casadevall","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108866_bib153","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.micpath.2026.108866_bib154","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.micpath.2026.108866_bib155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-022-00941-z","article-title":"SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib156","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bbi.2024.10.032","article-title":"SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model","volume":"123","author":"Kaur Sardarni","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.micpath.2026.108866_bib157","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMc2100362","article-title":"New SARS-CoV-2 variants - clinical, public health, and vaccine implications","volume":"384","author":"Abdool Karim","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2026.108866_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1582783","article-title":"Acute COVID-19 and LongCOVID syndrome - molecular implications for therapeutic strategies - review","volume":"16","author":"Michalak","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108866_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1014092","article-title":"Fueling silence: metabolic control of latent viral infection","volume":"22","author":"You","year":"2026","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108866_bib160","article-title":"Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108866_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107613","article-title":"Therapeutic potential of resveratrol against emerging respiratory viral infections","volume":"214","author":"Filardo","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108866_bib162","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/microorganisms11010183","article-title":"Influenza treatment: limitations of antiviral therapy and advantages of drug combination therapy","volume":"11","author":"Batool","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108866_bib163","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.micpath.2026.108866_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29643","article-title":"Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses","volume":"96","author":"Tang","year":"2024","journal-title":"J. Med. Virol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:31:18Z","timestamp":1791747078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":164,"alternative-id":["S0882401026005929"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108866","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory viruses and pulmonary diseases: Mechanisms, therapies, and metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108866"}}